Direct spasmolytics include the following drugs EXCEPT:

Questions 41

ATI RN

ATI RN Test Bank

Gastrointestinal drugs Questions

Question 1 of 5

Direct spasmolytics include the following drugs EXCEPT:

Correct Answer: B

Rationale: In the context of gastrointestinal drugs, direct spasmolytics are medications that act directly on smooth muscle to reduce spasms and cramping. In this question, the correct answer is B) Atropine sulfate. Atropine is not a direct spasmolytic but rather an anticholinergic drug that works by blocking acetylcholine receptors, leading to relaxation of smooth muscle. A) Aminophylline is a bronchodilator that works by relaxing bronchial smooth muscle and is not typically used as a direct spasmolytic in the gastrointestinal tract. C) Mebeverine is a direct spasmolytic commonly used to relieve symptoms of irritable bowel syndrome by acting directly on smooth muscle in the intestines to reduce spasms and abdominal pain. D) Papaverine is another direct spasmolytic drug that works by inhibiting phosphodiesterase, leading to smooth muscle relaxation in the blood vessels and other organs. Understanding the differences between these drugs is crucial for healthcare professionals when selecting the appropriate medication for patients with gastrointestinal issues. By knowing the mechanisms of action and specific uses of each drug, healthcare providers can make well-informed decisions to ensure optimal patient outcomes.

Question 2 of 5

All of following drugs can be used in treatment of peptic ulcer, EXCEPT:

Correct Answer: D

Rationale: In the treatment of peptic ulcers, it is important to understand the mechanisms of action of various drugs to make informed decisions. In this case, the correct answer is D) Prednisolone, as it is a corticosteroid that is not typically used in the treatment of peptic ulcers. A) Sucralfate is a medication that forms a protective layer over the ulcers, promoting healing by providing a barrier against acid and pepsin. B) Pirenzepine is an anticholinergic drug that reduces gastric acid secretion by blocking muscarinic receptors, thus helping to relieve symptoms and promote ulcer healing. C) Bismuth salts have both antimicrobial and mucosal protective effects, making them effective in eradicating H. pylori infections and reducing inflammation in the stomach lining. Prednisolone (Option D), on the other hand, is a corticosteroid that is more commonly used for its anti-inflammatory properties in conditions like asthma, autoimmune disorders, and severe allergies. Its use in peptic ulcer treatment is limited due to the risk of worsening gastric irritation and potentially causing ulcers. Understanding the mechanisms of action of these drugs is vital for healthcare professionals to make appropriate treatment decisions for patients with peptic ulcers. It is essential to choose drugs that target the underlying causes of ulcers while minimizing side effects and complications.

Question 3 of 5

A 52-year-old patient is taking well adjusted dosages of theophylline, warfarin, quinidine, and phenytoin for multiple medical problems. However, he starts taking a drug for some GI distress, but he presents with toxic effects from all his other medications, with elevation of their serum concentrations. Which was the drug the patient most likely took?

Correct Answer: A

Rationale: In this scenario, the correct answer is A) Cimetidine. Cimetidine is a known inhibitor of the cytochrome P450 enzyme system in the liver, which is responsible for metabolizing many drugs, including theophylline, warfarin, quinidine, and phenytoin. By inhibiting this enzyme system, cimetidine can lead to increased serum concentrations of these medications, causing toxic effects. Now, let's discuss why the other options are incorrect: - B) Sucralfate: Sucralfate does not have a significant interaction with the cytochrome P450 system and is less likely to cause the observed toxic effects. - C) Famotidine: Famotidine is not known to significantly interact with the cytochrome P450 system and is less likely to cause the observed toxic effects. - D) Nizatidine: Similar to famotidine, nizatidine is not a potent inhibitor of the cytochrome P450 system and is less likely to cause the observed toxic effects. From an educational perspective, this scenario highlights the importance of understanding drug-drug interactions, particularly with medications that can inhibit or induce cytochrome P450 enzymes. Healthcare providers should be aware of potential interactions when prescribing medications to patients who are already taking multiple drugs to prevent adverse effects and ensure patient safety.

Question 4 of 5

A 45-year-old patient who is taking a proton pump inhibitor, metronidazole, and clarithromycin. Which of the following is the most likely purpose for administering this drug combination?

Correct Answer: C

Rationale: The correct answer is C) Refractory or recurrent, and severe, gastric or duodenal ulcers secondary to H. pylori. This drug combination of a proton pump inhibitor, metronidazole, and clarithromycin is commonly used to eradicate Helicobacter pylori (H. pylori) infection in patients with persistent, severe, or recurrent gastric or duodenal ulcers. H. pylori is a major cause of peptic ulcers, and eradicating this bacterial infection helps in healing and preventing the recurrence of ulcers. Option A, Antibiotic-associated pseudomembranous colitis, is treated with different antibiotics like vancomycin or fidaxomicin, not with the combination mentioned. Option B, Irritable bowel syndrome (IBS), is a chronic functional gastrointestinal disorder that does not typically require treatment with this specific drug combination. Option D, Traveler's diarrhea, is usually caused by bacterial pathogens like Escherichia coli and is typically treated with antibiotics like azithromycin or fluoroquinolones, rather than the combination provided. Educationally, understanding the rationale behind using specific drug combinations for certain conditions is crucial for healthcare professionals to make informed decisions in clinical practice and provide optimal patient care based on evidence-based guidelines and treatment protocols.

Question 5 of 5

A patient undergoing cancer chemotherapy gets ondansetron for prophylaxis of drug-induced nausea and vomiting. Which of the following best describes this drug's main mechanism of action in this setting?

Correct Answer: B

Rationale: The correct answer is B) Blocks central serotonin (5-HT3) receptors. Ondansetron, a 5-HT3 receptor antagonist, is commonly used to prevent chemotherapy-induced nausea and vomiting by blocking serotonin receptors in the chemoreceptor trigger zone and the gastrointestinal tract. Serotonin plays a key role in triggering the vomiting reflex, so by blocking these receptors, ondansetron effectively reduces nausea and vomiting. Option A is incorrect because ondansetron does not activate opioid receptors; instead, it acts on serotonin receptors. Option C is incorrect as ondansetron does not block dopamine receptors. Option D is incorrect because ondansetron does not act on histamine H1 receptors in the brainstem and inner ear. In an educational context, understanding the mechanism of action of gastrointestinal drugs like ondansetron is crucial for healthcare professionals managing patients undergoing chemotherapy. Knowing how specific drugs work helps in selecting the most appropriate treatment to effectively manage side effects and improve patient outcomes.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions